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Background: Self-reported use of Complementary and Alternative Medicine (CAM) varies widely from 10% to 75% in
the general populations worldwide. When limited to use of a CAM provider 2% to 49% reported use is found. CAM use
is believed to be closely associated with socio demographic variables such as gender, age, education, income and
health complaints. However, studies have only occasionally differentiated CAM use according to gender. Therefore, the
aim of the study presented here is to describe the prevalence of CAM use on the background of gender and to
describe the specific characteristics of male and female users in the total Tromsø 6 population.
Methods: A total of 12,982 men and women aged 30–87 in the municipality of Tromsø, Norway went through a
health screening program and completed two self-administered questionnaires in 2007/2008. The questionnaires were
developed specifically for the Tromsø study and included questions about life style and health issues in addition to
socio demographic variables.
Results: A total of 33% of the participants reported use of any CAM within the last 12 months, women more often
than men (42% and 24%, respectively). When limited to visits to a CAM provider, we found 17% use among women
and 8% among men. The relationship between the demographic variables and being a CAM user differed significantly
between men and women with regard to age, household income, and marital status. We did not find significant
differences between men and women concerning education and self-reported health.
Conclusions: Findings from this study suggest that the prevalence and associations for use of CAM differ between
men and women concerning several socio demographic variables (age, education and household income). Neglect of
women’s health care needs in public health care may contribute to the fact that women to a higher degree than men
turn to CAM and CAM products.
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The use of Complementary and Alternative Medicine
(CAM), including a range of different therapeutic modal-
ities such as homeopathy, acupuncture and hands on heal-
ing, has for many years increased significantly in the
Scandinavian countries [1] and elsewhere [2] but seems to
have been stabilized in recent years [3,4]. Self-reported use
of any CAM in the general population varies from 10% to
75% worldwide. When restricted to visiting a CAM pro-
vider, the prevalence of use fluctuates between 2% and 49%* Correspondence: agnete.kristoffersen@uit.no
1The National Research Center in Complementary and Alternative Medicine
(NAFKAM), Department of Community Medicine, Faculty of Health Sciences,
UiT The Arctic University of Norway, Tromsø, Norway
Full list of author information is available at the end of the article
© 2014 Kristoffersen et al.; licensee BioMed Ce
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.[5,6]. These large variations in reported use are mainly due
to differences in the definition of a CAM user [7].
In 2008 16% of the Norwegian population had visited
a CAM provider during the past 12 months, 22% of
these were women and 9% were men [8]. In 2012 CAM
was received within or outside the public health care by
36.6% of Norwegians. When use of CAM self-help tech-
niques and CAM over the counter (OTC) products were
added, 53.6% of the women and 36.5% of the men re-
ported such use [3].
In Norway regional cohort studies have been conducted
in Nord-Trøndelag (HUNT) and in Tromsø (The Tromsø
Cohort study, T1-T6). In the HUNT study, visits to a
CAM provider have been studied twice, in 1997 and in
2008. In 1997 a total of 9% of the respondents reported tontral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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The proportion was 13% in 2008 [9]. In the Tromsø study,
the use of CAM was investigated in the 3rd (T3), 4th (T4),
5th (T5), and 6th (T6) study conducted in 1986/87, 1994/
95, 2001/02 and 2007/08, respectively. The use of a CAM
provider during the last 12 months in the 5th Tromsø
study was found to be similar to the results in HUNT
(1997) [10].
Based on data from large cross sectional surveys, the
use of CAM is believed to be closely associated with socio
demographic variables such as gender, age, education, in-
come and health complaints [5]. Issues such as control
and participation in treatment, perception of illness, nat-
ural treatment, holism and philosophy of life have been
found to be related to the use of CAM [11,12].
Over the last decades researchers in the medical field
have shown a growing interest in gender and differences
between men and women in health, disease and health be-
haviour [13,14]. Research has shown that factors such as
different biological processes, conditions in daily life, en-
vironmental experiences, risk behaviours and different re-
sponses to stressful events may contribute to variation in
health and well-being in men and women [13-15]. There
is also evidence that women are seldom offered the same
treatment as men, even though they suffer the same med-
ical conditions, and there was no medical or clinical rea-
son for the treatment choice. Moreover, studies show that
women are less likely than men to receive more advanced
diagnostic and therapeutic interventions [16-18]. This
phenomenon raises the question of gender bias.
In the field of CAM research there are few studies fo-
cusing on gender issues, but studies generally demonstrate
that men use CAM to a lesser degree than women. Studies
focusing on CAM use often focus on particular patient
populations, for example patients with pain or different
types of cancer. As a matter of fact, measuring gender dif-
ferences in CAM use based on a few disorders may be as-
sociated with a gender bias because the disorders may
have different prevalence with regard to gender. Only large
prospective population studies, such as the Tromsø study,
have the potential to reveal an unbiased perspective with
regard to gender differences of CAM use in the total
population. However, this topic has rarely been studied in
great population studies. Therefore, the aim of the study
presented here is to describe the prevalence and character-
istics of male and female users of CAM in the total
Tromsø 6 population.Methods
A total of 12,982 men and women aged 30–87 in the mu-
nicipality of Tromsø, Norway went through a health
screening program and completed two self-administered
questionnaires in 2007/2008.The Tromsø Study series (1–6) are single-centered pro-
spective, population-based health surveys of the adult in-
habitants of the municipality of Tromsø, North Norway
[19]. The population of Tromsø reflects the distribution of
gender, educational level and average income in Norway
overall, but the population is somewhat younger [20]. The
design includes repeated population health surveys to
which total birth cohorts and random samples are invited.
The letter of invitation contained a short questionnaire.
Individuals, who attended the survey by undergoing a
health screening and answered the first questionnaire,
subsequently received a second, more detailed question-
naire that they were asked to complete and return at site
or later by mail.
The two questionnaires included questions on the gen-
eral health status, diseases suffered by the respondent or
their family, muscle pain and physical discomfort, food
habits, alcohol consumption, smoking habits, physical
activity in leisure time, level of education, use of medi-
cine and use of health services including CAM. The
questions regarding CAM use were not related to any
specific disease condition. The questionnaires have not
been validated, however, a Cronbach’s alpha test of in-
ternal consistency of the questions analyzed in this paper
was 0.403.
The health screening included measuring of height,
weight, waist and hip circumference and blood pressure.
A blood sample was also taken to measure serum total
cholesterol, HDL-cholesterol, triglycerides and glucose.
In Norway a CAM provider is understood as a practi-
tioner providing CAM both as alternative and comple-
mentary treatment. A CAM provider offers therapies
that are mostly offered outside the public health care
service and paid out-of-pocket by the patients them-
selves when fees are required.
Study participants were classified as “CAM-users” by
checking YES for one or more of the following questions:
1. Have you during the last 12 months seen an
alternative provider (homeopath, acupuncturist, foot
zone therapist, herbal medicine practitioner, laying
on of hands practitioner, healer, clairvoyant etc.)?
2. In the last 12 months, have you used herbal or
“natural” medicine?
3. In the last 12 months, have you used meditation,
yoga, qi gong or Tai Chi as self-treatment?
Accordingly, a participant who checked NO for all the
three specific CAM-questions was classified as a non-user.
The parenthesis examples in question 1 include examples of
both modern CAM modalities and traditional healing as it
is practiced in North Norway. Traditional healers are non-
professional and non-commercial therapists who are closely
connected to the local culture and world-views [21,22].
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Research Center in Complementary and Alternative
Medicine (NAFKAM) 6 level cumulative model for clas-
sifying CAM use [7]. In this model the different levels
are included in each other (Table 1).
Informants who had seen a chiropractor were not de-
fined as CAM users in this study as chiropractors are
regulated health care personnel in Norway. This also ap-
plies to informants who had used cod liver oil, Omega-3
capsules, calcium tablets or ordinary vitamins/mineral
supplements as these supplements are commonly used
in the Norwegian population.
The data were analyzed using chi-square tests and
Anova Table in SPSS Windows (version 19.0, SPSS Inc.,
Chicago, IL).
The Norwegian Data Protection Authority has been no-
tified about the study, and The Regional Committee for
Medical and Health Research Ethics has recommended it.
The participants have given their informed, written
consent.
Results
Basic characteristics of the studied participants
The studied population (n = 11104) consisted of 5,877
women (52.9%) and 5,227 men (47.1%). The response
rate to the study was 65.7%. After exclusion of missing
response to the CAM questions, the response rate
reached 56%, 58% among women and 54.3% among men
Figure 1.
The studied population was a rather healthy and gen-
der balanced population with a median age of 58. More
than 92% defined themselves as being of Norwegian
heritage. The largest majority of the remaining 8% de-
fined themselves as being of indigenous Sami people
and/or Kven, descendants of Finnish immigrants. The
largest differences between men and women were with
regard to income, partner and visits to a general practi-
tioner (GP) (Table 2).
Gender differences in prevalence of CAM use
A total of 1,423 participants (13.1%) had seen a CAM
provider at least once within the past year (CAM level
2) of which 535 participants (4.8%) had seen the pro-
vider more than three times (CAM level 1). A total of
3,730 (33.3%) had seen a CAM provider, used CAMTable 1 Gender differences in CAM use last 12 months accord
use
Tota
CAM 1 (seen a CAM provider more than 3 times) (
CAM 2 (seen a CAM provider at least once) (n
CAM 3 (seen a CAM provider, used OTC products or CAM techniques) (n
*Pearson Chi-Square test.OTC-products and/or used CAM techniques (CAM
level 3) within the past year. Women used CAM signifi-
cantly more often than men at all levels (Table 1).
Gender related associations for CAM use
The relationship between the demographic variables and
being a CAM user differed significantly between men
and women with regard to age (CAM level 3), household
income (CAM levels 2 and 3) and marital status (CAM
levels 1–3). We did not find significant differences be-
tween men and women concerning education or self-
reported health (Table 3).
In the sex-disaggregated analysis, we found that poor
health, young or middle age was significantly associated
with CAM use at all CAM levels in women. We also
found university education to be associated with CAM
use at levels 1 and 3, and that divorced/separated
women tended to use more CAM at level 3. We did not
find household income to be associated with CAM use
at any level among women (Table 4).
Among men we found that poor health was associated
with CAM use at all CAM levels while older age, lower
income and being a widower was associated with CAM
use at CAM level 3 (Table 5).
Common in both men and women was that poor
health was associated with CAM use at all levels. At
levels 1 and 2, the CAM users tended to be younger
compared to the non-user in both men and women,
while the oldest group was the most frequent CAM user
among men at level 3 (Tables 4 and 5).
While lower income is associated with CAM use at
level 3 for men, income was not associated with CAM
use at all among women (Tables 4 and 5).
Discussion
Results from this study indicate that women were gener-
ally more likely to use CAM at all levels. For both men
and women, poor health was associated with CAM
utilization at all levels. Moreover, younger age was asso-
ciated with the use of CAM at all levels for women.
Household income in women and university education
in men were not associated with the use of CAM at any
level.
Many studies report use of CAM in populations. How-
ever, the study population, time frame in use and definitioning to NAFKAMS cumulative model for reporting CAM
l (n = 11104) % Women (n = 5877) % Men (n = 5227) % p-value*
n = 535) 4.8% (n = 353) 6% (n = 182) 3.5% <0.000
= 1423) 13.1% (n = 995) 17.4% (n = 428) 8.3% <0.000
= 3730) 33.3% (n = 2471) 42.0% (n = 1259) 24.1% <0.000
Figure 1 Flow chart that shows the selection of the studied population.
Table 2 Basic characteristics of the studied participants
Total (n = 11104) Women (n = 8577) Men (n = 5227) p-value
Percentage women 52.9
Mean age 56.75 56.58 56.94 0.1182
Median age (range) 58 (30–87) 58 (30–87) 59 (30–87)
Living with a spouse/partner % 75.9 69.8 82.5 <0.0001
University degree % 39.9 38.8 41 <0.0001
Self-reported good health % 67 66.2 68 <0.0001
Self-reported poor health % 5.2 5.8 4.5 <0.0001
Mean self-reported health (0–100) 77.5 77.1 78 0.0322
Median self-reported health (0–100) 80 80 80
More than 400 000 NOK in household income during
past 12 months % (69 000$/52000€)
62.9 56.9 69.4 <0.0001
Less than 125 000 NOK (21 500 $/16 400 €) in household
income during past 12 months %.
2.5 3.6 1.3 <0.0001
Seen a GP during past 12 months % 82.2 86 77.9 <0.0001
1Pearson Chi-Square test.
2Anova test.
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Table 3 Socio demographic characteristics with comparison between female and male users of CAM
CAM 11 CAM 22 CAM 33
Women Men Women Men Women Men
% (n) % (n) p-value* % (n) % (n) p-value* % (n) % (n) p-value*
Age 0.195 0.318 0.000
30-39 7.4 (26) 4.9 (9) 5.7 (57) 4.4 (19) 4.2 (105) 2.9 (37)
40-59 58.6 (207) 53.8 (98) 53.9 (536) 51.4 (220) 52.5 (1297) 44.1 (555)
60+ 34 (120) 41.2 (75) 40.4 (402) 44.2 (189) 43.3 (1069) 53 (667)
Education 0.441 0.569 0.268
Primary/Secondary 52.3 (183) 55.8 (101) 59.9 (591) 61.6 (261) 58.5 (1432) 60.4 (751)
College/University education 47.7 (167) 44.2 (80) 40.1 (395) 38.4 (163) 41.5 (1017) 39.6 (493)
Self-reported health 0.984 0.962 0.439
Bad 8.2 (29) 8.2 (15) 10.3 (102) 10.4 (44) 7.9 (194) 6.8 (85)
Neither good nor bad 30.6 (108) 31.3 (57) 33.8 (333) 33 (140) 31 (759) 32.1 (400)
Good 61.2 (216) 60.4 (110) 55.9 (551) 56.6 (240) 61.1 (1499) 61.1 (763)
Marital status 0.000 0.000 0.000
Single 21.2 (75) 24.2 (44) 18.8 (187) 24.1 (103) 17.3 (427) 18.7 (236)
Married/Registrated partner 52.1 (184) 64.3 (117) 51.9 (516) 62.6 (268) 54.9 (1356) 64.3 (810)
Widow/Widower 9.3 (33) 1.6 (3) 11.1 (110) 2.1 (9) 10.3 (254) 4.2 (53)
Divorced/Separated 17.3 (61) 9.9 (18) 18.3 (182) 11.2 (48) 17.6 (343) 12.7 (160)
Household income . 0.331 0.005 0.012
Low 24.5 (80) 18.5 (33) 26.6 (243) 18.4 (75) 26 (590) 21.5 (261)
Middel 33 (108) 36 (64) 34 (310) 36.4 (148) 33.8 (766) 34.9 (423)
High 42.5 (139) 45.5 (81) 39.4 (360) 45.2 (184) 40.2 (913) 43.6 (528)
1CAM 1 = Use of a CAM provider minimum 4 times last year.
2CAM 2 = Use of a CAM provider last year.
3CAM 3 = Use of a CAM provider, CAM OTC products or CAM techniques last year.
*Pearson Chi-Square test.
Comparison between female and male users of CAM.
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ies, we have chosen to compare our study to a limited se-
lection of other studies.
The most comparable study is the HUNT 3 study con-
ducted in the county of Nord-Trøndelag, Central Norway
in 2008. They found similar use at CAM level 2 as shown
in the results from our study [9].
The previous Tromsø study (the 5th Tromsø study),
conducted in 2001/2002 reported lower use of CAM at
level 2 compared to results from our group six years
later (13.5% in women and 4.8% in men without cancer
or coronary heart disease) [10]. The higher use of CAM
in this study might be due to a general increase in the
use of CAM between 2002 and 2008 [6,23]. The pre-
prepared list regarding the CAM providers might have
improved the recall and clarified what to consider as
CAM, and thereby increased the reported rate of CAM
use [6].
The findings of 33.3% use at CAM level 3 are in ac-
cordance with a recent review that found 32.2% preva-
lence of use in the 16 studies included [2]. The findingsfrom our study are also in accordance with findings from
the UK and the US presented in another recent review [5].
However, our data report a lower prevalence of use than
findings from Australia and South Korea [5]. The reason
for this might be that South Korea has a stronger tradition
of using traditional medicine, and that Australia is more
influenced by traditional Eastern medicine due to geo-
graphical proximity.
The findings of a strong association between CAM use
and being a young/middle age women with higher educa-
tion and poor health, is in line with other studies
[1,24-26]. That women in this study used CAM more
often than men at all levels was also in line with previous
research, showing that women tend to be more active in
their own health promotion and are more concerned
about health issues and caring compared to men [13,27].
Throughout the Western world women more often under-
take health care visits [28-30], are more frequent utilizers
of psychological support groups [31,32] and of health ad-
vice on the Internet [33], and the typical reader of a self-
help book is a woman. The presence of a gender bias in
Table 4 Socio demographic characteristics of female users and nonusers of CAM
CAM 11 CAM 22 CAM33
Non-users Users Non-users Users Non-users Users
% (n) % (n) p-value* % (n) % (n) p-value* % (n) % (n) p-value*
Age 0.000 0.000 0.000
30-39 90 (234) 10 (26) 78.2 (205) 21.8 (57) 60.7 (162) 39.3 (105)
40-59 92.4 (2534) 7.6 (207) 80.8 (2262) 19.2 (536) 54.9 (1576) 45.1 (1297)
60+ 95.3 (2423) 4.7 (120) 84.8 (2248) 15.2 (402) 60.9 (1668) 39.1 (1069)
Education 0.001 0.434 0.000
Primary/Secondary 94.5 (3140) 5.5 (183) 82.9 (2858) 17.1 (591) 59.7 (2124) 40.3 (1432)
College/University education 92.3 (1999) 7.7 (167) 82.1 (1806) 17.9 (395) 54.9 (1238) 45.1 (1017)
Self-reported health 0.012 0.000 0.000
Bad 90.2 (266) 9.8 (29) 67.8 (215) 32.2 (102) 42.8 (145) 57.2 (194)
Neither good nor bad 92.9 (1413) 7.1 (108) 78.9 (1244) 21.1 (333) 53.4 (870) 46.6 (759)
Good 94.2 (3478) 5.8 (216) 85.4 (3226) 14.6 (551) 61.2 (2367) 38.8 (1499)
Marital status 0.172 0.084 0.006
Single 92.3 (902) 7.7 (75) 81.2 (808) 18.8 (187) 57.9 (588) 42.1 (427)
Married/Registrated partner 94 (2877) 6 (184) 83.5 (2613) 16.5 (516) 57.9 (1866) 42.1 (1356)
Widow 94.7 (587) 5.3 (33) 83.3 (550) 16.7 (110) 63.1 (435) 36.9 (254)
Divorced/Separated 93.1 (825) 6.9 (61) 80.3 (744) 19.7 (182) 54.4 (517) 45.6 (434)
Household 0.711 0.510 0.101
Low 94 (1264) 6 (80) 82.7 (1161) 17.3 (243) 59.3 (861) 40.7 (590)
Middel 93.5 (1541) 6.5 (108) 81.7 (1383) 18.3 (310) 55.7 (963) 44.3 (766)
High 93.6 (1959) 6.6 (139) 83.1 (1771) 16.9 (360) 58.1 (1266) 41.9 (913)
1CAM 1 = Use of a CAM provider minimum 4 times last year.
2CAM 2 = Use of a CAM provider last year.
3CAM 3 = Use of a CAM provider, CAM OTC products or CAM.
Techniques last year.
*Pearson Chi-Square test.
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care needs [17], might also contribute to women turning
away from conventional patterns of care towards CAM
providers and products.
Recent in-depth studies among Norwegian women
using CAM support the findings that the public healthcare
system in Norway may be unable to meet all the needs of
female patients. The results illustrate subjectively experi-
enced barriers related to the communication, understand-
ing, and treatment of illness. Women diagnosed with
breast cancer and multiple sclerosis express unmet needs
with regard to their individual health care goals. They
strongly emphasize the importance of CAM as a health
care system that enables them to take active part in
decision-making processes and treatment and, thereby,
contribute to positive health outcomes for themselves.
They not only relate to scientific, medical knowledge but
also to experience-based knowledge (e.g., bodily experi-
ences) [34,35] as an important basis for their treatment
decisions. By the decision to use CAM, and even in some
cases to delay or decline conventional treatment, femaleCAM users differ from the expected patient behavior and
challenge the rationality of medical advice which tradition-
ally has been defined and provided by men [34,35].
However, another reason for the higher use in women
might be the fact that women generally utilize more
health services than men [13,36]. Together with the po-
tential implications gender bias in healthcare has for
women [17], this would explain why generally more
women feel the need to seek alternatives to conventional
care.
Women’s widespread use of CAM in Western countries
has also been suggested as an expression of traditional
gender roles and dominant discourses of femininity, as be-
ing “help-seeking” and adhering to the “patient role” is
more in coherence with a traditional femininity than mas-
culinity [37,38]. The lower use of CAM among men may
be explained by the fact that men adapt to preconceptions
about a masculine behavior with little room for showing
weakness and a need for help and support [27], and poten-
tially the fact that their health care needs are better met
within the public health care [17]. Another explanation is
Table 5 Socio demographic characteristics of male users and nonusers of CAM
CAM 11 CAM22 CAM33
Non-users Users Non-users Users Non-users Users
% (n) % (n) p-value* % (n) % (n) p-value* % (n) % (n) p-value*
Age 0.154 0.202 0.001
30-39 95.3 (181) 4.7 (9) 90 (171) 10 (19) 80.5 (153) 19.5 (37)
40-59 96 (2365) 4 (98) 84.8 (2272) 8.8 (220) 77.9 (1953) 22.1 (555)
60+ 96.9 (2370) 3.1 (75) 92.4 (2295) 7.6 (189) 73.6 (1862) 26.4 (667)
Education 0.416 0.255 0.245
Primary/Secondary 96.6 (2864) 3.4 (101) 91.3 (2755) 8.7 (261) 75.4 (2300) 24.6 (751)
College/University education 96.2 (2004) 3.8 (80) 92.2 (1937) 7.8 (163) 76.8 (1631) 23.2 (493)
Self-reported health 0.008 0.000 0.000
Bad 93.2 (204) 6.8 (15) 80.7 (184) 19.3 (44) 63.4 (147) 36.6 (85)
Neither good nor bad 95.9 (1322) 4.1 (57) 90 (1267) 10 (140) 72.1 (1032) 27.9 (400)
Good 96.8 (3361) 3.2 (110) 93.1 (3262) 6.9 (240) 78.4 (2769) 21.6 (763)
Marital status 0.240 0.074 0.023
Single 95.6 (950) 4.4 (44) 89.8 (907) 10.2 (103) 76.7 (779) 23.3 (236)
Married/Registrated partner 96.5 (3199) 3.5 (117) 92 (3088) 8 (268) 76.2 (2587) 23.8 (810)
Widower 97.6 (143) 2.1 (3) 93.9 (139) 6.1 (9) 65.6 (101) 34.4 (53)
Divorced/Separated 97.2 (624) 2.8 (18) 92.6 (604) 7.4 (48) 75.8 (501) 24.2 (160)
Household income 0.484 0.135 0.000
Low’ 96.2 (835) 3.8 (33) 91.5 (809) 8.5 (75) 71.1 (642) 28.9 (261)
Middel 96 (1539) 4 (64) 90.9 (1472) 9.1 (148) 74.2 (1219) 25.8 (423)
High 96.7 (2375) 3.3 (81) 92.6 (2297) 7.4 (184) 78.9 (1969) 21.1 (528)
1CAM 1 = Use of a CAM provider minimum 4 times last year.
2CAM 2 = Use of a CAM provider last year.
3CAM 3 = Use of a CAM provider, CAM OTC products or CAM technuiques last year.
*Pearson Chi-Square test.
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health as being more “mechanical” than women, and that
they, therefore, are less attracted to CAM where whole-
ness, communication and personal relation are more pro-
nounced than the detailed biological mechanism [38].
The higher education among women using CAM was
expected to correlate with the younger age. Analyzes ad-
justed for age, however, still show significant associations
related to education. Women with higher education might
be more able to find relevant information about CAM and
to afford such treatment use. It can be speculated, that the
higher educational background of women with a univer-
sity education leads to higher self-confidence especially
since even in modern Norway, it is not entirely the rule
that women and men have the same education, in particu-
lar not for all of the age groups in this sample. It is not un-
likely that this higher self-esteem makes females less apt
to accept terms and conditions of treatment that they do
not feel entirely comfortable with.
The lack of income differences between the users and
non-users of CAM is in line with several other studies
[26]. Recent studies suggest that CAM no longer is aphenomenon restricted to unique segments enjoying
high family income [39].
Limitations
Despite the large sample size, the response rate (65.7%)
could have influenced the generalizability of our findings
as the non-responders differed from the responders con-
cerning age and sex. Men in the oldest and youngest age
groups and women in the oldest age group had the low-
est response rate. However, the non-responders in these
groups consist of only 391 responders. Therefore, even
though these groups would have been expected to use
CAM to a lesser degree, the number of non-responders
in these groups is so low that the likelihood of substan-
tially influencing the final results is small.
The generalizability was also influenced by the 1,878
respondents that were excluded from the study due to
missing response to the CAM questions. Generally, non-
response to a CAM question is more likely to mean no
use leading to an overestimated use of CAM in the ana-
lysis [40]. A non-responder-analysis, however, where the
non-responders to the CAM questions are assumed to
Kristoffersen et al. BMC Complementary and Alternative Medicine 2014, 14:463 Page 8 of 9
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the same, though the significant level varies slightly.
The 12-month recall period concerning the use of
CAM, might result in inaccuracies regarding the report
of use. However, this factor is equally distributed be-
tween men and women.
One of the three questions regarding CAM asked for
the use of herbal or “natural medicine” without defining
this further. This could constitute an over- or underre-
porting of such use depending on how each participant
defined their use. Moreover, young and old participants,
men and women, might define this in different ways.
Traditional healing and CAM therapies might have
different prevalence and associations for use. Both are
combined in the same question, which makes a differen-
tiation between associations for CAM and traditional
healing, difficult.
Conclusion
Findings from this study suggest that the prevalence and as-
sociations for use of CAM differ between men and women
concerning several socio demographic variables (age, edu-
cation and household income). Norwegian women use
CAM significantly more often than men at all levels of the
use of CAM. The study revealed a strong association be-
tween the use of CAM and being a young/middle aged
women with higher education and poor health.
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